Still amazes me, though, how a company like BNTX can attract that kind of capital infusion with little to no validation of it's science yet IPIX, and Brilacidin in particular, cannot attract one BP willing to pony up what they all know the platform is worth, or to date even a small percentage of such value. That is why I hope we really stick it to some BP into paying top dollar since none showed us any support whatsoever when they were really needed over the past years.